ASCO GUIDELINES Bundle

Malignant Pleural Mesothelioma

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1475472

Contents of this Issue

Navigation

Page 3 of 9

Diagnosis ➤ In surgical, thoracoscopic, or open pleural biopsies with sufficient tissue, further subtyping and quantification of epithelial vs. sarcomatoid components of mesothelioma may be undertaken. (Moderate Recommendation; IC) ➤ The non-tissue based biomarkers that are under evaluation at this time do not have the sensitivity or specificity to predict outcome or monitor tumor response and are therefore NOT recommended. (Moderate Recommendation; EB-I) ➤ While tumor genomic sequencing is currently done on a research basis in mesothelioma and it may become clinically applicable in the near future, it is NOT recommended at this time. (Moderate Recommendation; EB-I) Staging ➤ A CT scan of the chest and upper abdomen with IV contrast is recommended as the initial staging in patients with mesothelioma. (Strong Recommendation; EB-I) ➤ An FDG PET/CT should usually be obtained for initial staging of patients with mesothelioma. This may be omitted in patients who are not being considered for definitive surgical resection. (Strong Recommendation; EB-I) ➤ If abnormalities that suggest metastatic disease in the abdomen are observed on a chest and upper abdomen CT or on a PET/CT then consideration should be given to perform a dedicated abdominal (+/- pelvic) CT scan, preferably with IV and oral contrast. (Strong Recommendation; EB-I) ➤ An MRI (preferably with IV contrast) may be obtained to further assess invasion of the tumor into the diaphragm, chest wall, mediastinum and other areas. (Moderate Recommendation; EB-I) ➤ For patients being considered for maximal surgical cytoreduction, a mediastinoscopy and/or endobronchial US should be considered if enlarged and/or PET-avid mediastinal nodes are present. (Strong Recommendation; EB-I) ➤ In the presence of contralateral pleural abnormalities detected on initial PET/CT or chest CT scan, a contralateral thoracoscopy may be performed to exclude contralateral disease. (Moderate Recommendation; EB-I) ➤ In patients with suspicious findings for intra-abdominal disease on imaging and no other contraindications to surgery, it is strongly recommended that a laparoscopy be performed. (Strong Recommendation; EB-I)

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Malignant Pleural Mesothelioma